So if our starting premise is compliance with disclosure requirements of the ASX if they have material information they are legally obliged to disclose and cannot simply embargo. Otherwise everyone would sit on things to heighten emotion. I wonder if they are only able to release once the study is formally signed off by the regulator? Will reread and ponder. Mmmm
Ann: Imugene to Present HER-Vaxx Phase 2 Data at AACR21 Meeting, page-21
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $356.9M | |||
| Open | High | Low | Value | Volume |
| 4.8¢ | 4.9¢ | 4.8¢ | $109.8K | 2.262M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 68 | 10708185 | 4.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 4195289 | 21 |
View Market Depth
| Last trade - 15.21pm 11/10/2024 (20 minute delay) ? |
| IMU (ASX) Chart |